Half-Year 2022 Financial and Clinical Trials Update

Molecular Lab CER-Constant Exchange Rates CHFbn 2.4 1.8 1.2 0.6 0.0 2022 vs. 2021 CER growth +1% +29% -18% -2% +19% -15% +4% +4% ■ Virology HY 2020 | Cervical Cancer HY 2021 Blood Screening qPCR&NAP HY 2022 MD Systems Other ■Microbiology Roche 192

View entire presentation